Connect with us

Health

Growing Asthma Rate Fuelling Call for Respiratory Inhaler Devices

Published

on

By Dipo Olowookere

Future Market Insights (FMI) has delivered key insights on the global respiratory inhaler devices market in its upcoming outlook titled, ‘Respiratory Inhaler Devices Market: Global Industry Analysis and Opportunity Assessment, 2015 – 2025’.

In terms of value, the global respiratory inhaler devices market is projected to register a healthy CAGR of 4.3 percent during the forecast period due to various factors. This FMI report offers vital and detailed insights regarding these factors.

The respiratory inhaler devices market is segmented on the basis of product type, disease indications, technology and region. Based on the product segmentation, the overall market has been categorised into metered dose inhaler (MDI), dry powder inhaler (DPI) and nebuliser.

Nebulisers are further sub-segmented into ultrasonic nebuliser, mesh nebuliser and compressed air nebuliser. The metered dose inhaler segment is estimated to account for maximum share in the global respiratory inhaler devices market by 2015 end, and expected to register a CAGR of 4.5 percent in terms of value during the forecast period 2015-2025.

Currently, metered dose inhaler is a major contributor to market growth in Europe, North America and parts of Asia Pacific. Demand for nebulisers is expected to expand at a CAGR of 3.8 percent through 2025.

Increase in prevalence of asthma, COPD and other respiratory disorders, especially among paediatric and the geriatric population, is a major factor driving growth of the global respiratory inhaler devices market.

Other driving factors include strategic alliances among key players in the market, manufacturers focusing on enhancing market share, and expansion of the healthcare sector in developing countries due to growing investments by major players. Further, surge in demand for respiratory inhaler devices in all acute and moderate asthma and COPD conditions owing to increasing health awareness and growing disposable income is projected to result in increased spending on respiratory inhaler devices. This in turn is expected to bolster respiratory inhaler devices market growth during the forecast period.

Lack of effective drugs for certain respiratory disorders, concerns about side-effects and complications, lack of skilled pulmonologists and healthcare professionals, lack of awareness among patients, and high prices of inhaler devices are the key factors hampering growth of this market.

Currently, combined therapies offer more associated benefits, such as reliability, increased efficacy, and favourable reimbursement policies. Owing to these factors, patients with complex respiratory disorders are more inclined towards adopting such therapies.

However, the cost associated with combination therapies is higher as compared to conventional therapies for patients with complex respiratory disorders. The global respiratory inhaler devices market is expected to be driven by the increased usage of newly introduced triple combination therapy for COPD patients in the coming years.

This report assesses trends driving each segment and offers analysis and insights about the potential of respiratory inhaler devices market in specific regions. North America is estimated to dominate the respiratory inhaler devices market with maximum market share by end of 2015. North America and Western Europe are collectively expected to account for over 64.1 percent of the total respiratory inhaler devices market share in terms of value by end of 2015. Asia Pacific excluding Japan is estimated to witness highest CAGR of 5.0 percent over the forecast period, followed by North America, due to increasing prevalence of asthma and COPD among children and the geriatric population.

Some key companies covered in this report include AstraZeneca, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, Cipla Ltd., Koninklijke Philips N.V., PARI Medical Holding,Teva Pharmaceutical Industries Ltd., Beximco Pharmaceuticals Ltd., OMRON Healthcare Europe B.V. and Merck & Co., Inc.

Their primary focus is towards enhancing their product portfolio through research and development, introduction of innovative and cost-effective drugs and medical devices in order to gain market share and to strengthen their respective position in the global market.

Dipo Olowookere is a journalist based in Nigeria that has passion for reporting business news stories. At his leisure time, he watches football and supports 3SC of Ibadan. Mr Olowookere can be reached via [email protected]

Click to comment

Leave a Reply

Health

WHO Unhappy Over Trump’s Withdrawal of US Membership

Published

on

world health organization WHO

By Adedapo Adesanya 

The Director-General of the World Health Organisation (WHO), Dr Tedros Ghebreyesus, on Tuesday said the organisation regretted the decision of the United States to withdraw from it.

After his inauguration on Monday, the new US President, Mr Donald Trump, signed an executive order withdrawing the US from the global health body.

“The World Health Organisation regrets the announcement that the United States of America intends to withdraw from the Organization.

“The organisation hopes that Washington will change its decision.

“We hope the United States will reconsider and we look forward to engaging in constructive dialogue to maintain the partnership between the USA and WHO, for the benefit of the health and well-being of millions of people around the globe,” the health group stated in the statement.

This marks the second time Mr Trump has ordered the US to be pulled out of the world health body charged with global health welfare and monitoring.

Mr Trump was critical of how the international body handled COVID-19 and began the process of pulling out from the Geneva-based institution during the pandemic.

However, after Mr Trump lost to President Joe Biden in 2020, the erstwhile American president, who later reversed that decision.

With his return to office, Mr Trump, through the executive action on day one, makes it more likely the US will formally leave the global agency.

The executive order also said the withdrawal was the result of “unfairly onerous payments” the US made to the WHO, which is part of the United Nations (UN).

President Trump was critical of the organisation for being too “China-centric” in its tackling of the COVID-19 pandemic and accused the WHO of being biased towards the Asian nation in how it issued guidance during the outbreak.

Under the Biden administration, the US continued to be the largest funder of the WHO (around 14 per cent) and in 2023, it contributed almost one-fifth of the agency’s budget.

The organisation’s annual budget is $6.8 billion.

Continue Reading

Health

DoorSpace Exits Meta Platforms Over Fact-checking System

Published

on

DoorSpace

By Aduragbemi Omiyale

A healthcare technology platform, DoorSpace, has announced its exit from all Meta platforms, citing value differences and company culture as reasons for the action.

Ahead of the inauguration of Mr Donald Trump as the President of the United States of America (USA) for a second term on tomorrow, Monday, January 20, 2025, Mr Mark Zuckerberg announced changes to his platforms’ fact-checking system.

“The only way that we can push back on this global trend is with the support of the US government, and that’s why it’s been so difficult over the past four years, when even the US government has pushed for censorship,” Mr Zuckerberg said in a video.

He said Meta was welcoming political discourse back on Facebook, Instagram and Threads with the new Community Notes system, which will enable users to write and rate notes that can be added onto posts.

Mr Zuckerberg explained that Meta would be working closely with Mr Trump’s upcoming administration by showing users more content that is politically charged and not checked by third-party fact checkers.

This decision of Meta did not go down well with DoorSpace, which said it has ceased any activity and would no longer spend marketing dollars to advertise on Meta platforms.

“Zuckerberg’s business decisions to rollback its fact checking system and to open up the platform to allow for misinformation, hate and bullying, especially against vulnerable minority groups, shows his lack of understanding on the importance of diversity and common decency.

“Incel culture will continue to grow and fester in that curated environment, leading to more violence against these groups in the real world,” the chief executive of DoorSpace, Ms Sarah M. Worthy, said.

“”I need to stand by my values and use my position as a healthcare tech leader to advocate for the individuals who are directly harmed in both their professional and personal lives by the hate and misinformation being spread on Zuckerberg’s platforms.

“The Meta that Zuckerberg has created has become a cesspool that sells its users’ data to the highest bidder while utilizing manipulative and dangerous tactics to keep people on the app as long as possible,” Ms Worthy added.

“Your data is not secure on their platforms, their algorithmic feed is designed to sow division and misinformation, and the company has announced that it does not view every American equally.

“There is no need for our business to spend money advertising there or any reason for our brand to maintain an active presence there anymore,” she said further.

Continue Reading

Health

Mums Feel Warmth Initiative Raises Postpartum Depression Awareness

Published

on

Mums Feel Warmth Postpartum Depression

By Modupe Gbadeyanka

A transformative webinar to raise awareness on postpartum depression (PPD) by nursing mothers has been organised by MSc Media and Communication students from the School of Media and Communications of the Pan-Atlantic University.

The programme titled Beyond Baby Blues: Understanding and Overcoming Postpartum Depression was held on January 7, 2025.

It was put together by the students under the Mums Feel Warmth initiative, with experts in the field invited to speak on the matter aimed at empowering mothers and fostering a sense of reassurance.

The webinar was to highlight the journey through postpartum depression, offering a message of hope, resilience, and the importance of mental health support for mothers everywhere.

One of the speakers, Dr Laja Odunuga, who is the Care Coordinator for AVON HMO, explained the difference between the common “baby blues” and the more severe, long-lasting PPD.

The discussion highlighted how PPD can manifest not just as sadness but through severe fatigue, disconnection from the newborn, and loss of interest in activities, which can last well beyond the typical two-week period associated with baby blues.

Another expert, Ms Otomfon Ibanga, the Assistant Lead Nurse for Q-Life Family Clinic, emphasised the role of support systems, urging families and friends to be vigilant for signs of PPD and to provide a nurturing environment.

She also discussed prevention strategies, including prenatal planning for support structures and post-delivery management through therapy or medication.

On his part, Dr Chimaraoke Obialo, who is the Medical Director of Life Amada Health Consultancy, addressed the stigma surrounding PPD, advocating for education to transform societal perceptions from judgement to support.

The webinar underscored the need for community involvement, not just in recognising symptoms but in actively participating in the healing process by offering emotional and practical support.

The Mums Feel Warmth webinar was more than just an educational session; it was a call to action for society to embrace and support new mothers dealing with PPD.

By fostering open conversations and providing platforms for sharing experiences, Mums Feel Warmth continues to lead the charge against the stigma of PPD.

The commitment shown by the panellists and attendees alike promises a future where every mother has access to the understanding and care needed to navigate through the complexities of postpartum depression, ensuring that the joy of motherhood is not overshadowed by mental health challenges.

Mums Feel Warmth, with its core values of empathy, compassion, hope, community, and education, speaks to the Sustainable Development Goal 3, advocating for good health and well-being.

The initiative is breaking the silence around PPD, a condition that can significantly impact new mothers in the critical period following childbirth.

Continue Reading

Trending